Publications and Conferences

Our worldwide cancer research contributes to leading global health and medical journals. Here is a list of our peer-reviewed publications and upcoming conference engagements where Max team members will present and participate.

Publications

a stack of magazines or books from the max foundation

 

Peer-Reviewed Publications

Alicia Annamalay, Ph.D. Inés García González, B.A. Colin Forsyth, Ph.D., Mercedes Arteaga, B.Sc., Pat Garcia-Gonzalez, M.Sc. (2026) Treatment-free Remission in Chronic Myeloid Leukemia in Low- and Middle-Income Countries 

Cook, G., Wrigglesworth, J. M., & Garcia-Gonzalez, P. (2025) Max Access Solutions: An innovative model to bring life-saving medicines to low- and middle-income countries. Blood Global Hematology, accepted manuscript. On-line ahead of print version. 

Briercheck, E. L., Wrigglesworth, J. M., Garcia-Gonzalez, I., Scheepers, C., Ong, M. C., Venkatesh, V., Stevenson, P., Annamalay, A. A., Coffey, D. G., Anderson, A. B., Garcia-Gonzalez, P., & Wagner, M. J. (2024). Treatment access for gastrointestinal stromal tumor in predominantly low- and middle-income countries. JAMA Network Open, 7(4), e244898. 

Matsuzaki, M., Annamalay, A., Garcia-Gonzalez, P., & Radich, J. (2023). CML outcomes and care delivery during the COVID-19 pandemic in low- and middle-income countries. Current Hematologic Malignancy Reports, 18(1), 1-7.

Rowley, S., Garcia-Gonzalez, P., Radich, J.P., Novakowski, A.K., Usherenko, I., & Babigumira, J.B. (2021). Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries. Cost Effectiveness and Resource Allocation, 19(1), 18.

Umeh, C.A., Garcia-Gonzalez, P., Tremblay, D., & Laing, R. (2020). The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine, 19, 100257.

Malhotra, H., Radich, J., & Garcia-Gonzalez, P. (2019). Meeting the needs of CML patients in resource-poor countries. Hematology American Society of Hematology Education Program, 2019(1), 433-442.

Garcia-Gonzalez, P., Lopes, G., Schwartz, E., & Shulman, L.N. (2018). The role of humanitarian donations in decreasing preventable mortality from cancer in low-income countries: Models to improve access to life-saving medicines. Journal of Global Oncology, 4, 1-3.

Novakowski, A.K., Garcia-Gonzalez, P., Wrigglesworth, M., & Stergachis, A. (2018). A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience. Global Health, 14(1), 76.

Garcia-Gonzalez, P., Boultbee, P., & Epstein, D. (2015). Novel humanitarian aid program: The Glivec International Patient Assistance Program – Lessons learned from providing access to breakthrough targeted oncology treatment in low- and middle-income countries. Journal of Global Oncology, 1(1), 37-45. 

Sadak, K.T., Fultz, K., Mendizabal, A., Reaman, G., Garcia-Gonzalez, P., & Levine, P.H. (2014). International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations. Pediatric Blood & Cancer, 61(10), 1774-1778.

Mendizabal, A. M., Garcia-Gonzalez, P., & Levine, P. H. (2013). Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low- and middle-income countries. Cancer Epidemiology, 37(3), 247-254.

Garcia-Gonzalez, P., & Schwartz, E.L. (2012). Maximize Life Global Cancer Awareness Campaign: Improving the lives of cancer patients while increasing global awareness of their needs. Studies in Health Technology and Informatics, 172, 27-32.

Conferences 2026

Pat speaking to a group in a meeting references a projector screen

 

Consortium of Universities for Global Health (CUGH) | April 9-12 |Washington DC, United States

Several Max staff will participate in this annual conference that brings together academic institutions, global health practitioners, NGOs, policymakers, and students. CUGH is dedicated to advancing education, research, and collaboration on global health equity, health systems strengthening, and access to care worldwide.

Additionally, a partner organization will present a case study from Nepal on our collaboration.

PQMD Global Policy Forum | April 27-30 | New York City, United States

The Max CEO and Programs Director will attend the Partnership for Quality Medical Donations (PQMD) Global Policy Forum. This event convenes leaders from NGOs, pharmaceutical companies, policymakers, and logistics partners to discuss best practices, regulatory policy, quality standards, and ethical approaches to medical donation and access in low- and middle-income countries.

World Health Assembly | May 18-23 | Geneva, Switzerland

Several of Max staff including our CEO will attend the World Health Assembly. This is the World Health Organization’s primary decision-making body, where global health leaders and country delegations set priorities, negotiate resolutions, and shape policies affecting health systems, universal health coverage, and equitable access to treatment worldwide.

ASCO | May 29-June 2 | Chicago, United States

The Max CEO and Programs staff will attend an annual meeting considered the world’s premier oncology conference, where presenters share groundbreaking research, innovative treatments, and collaborative opportunities to improve cancer care globally. One Max staff member will present on a poster there titled Expanding access to tyrosine kinase inhibitors for treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia in low- and middle-income countries.

European Hematology Association | June 11-14 | Stockholm, Sweden

The Max CEO and Programs Director will attend the EHA Congress is one of the world’s leading scientific meetings in hematology, bringing together clinicians, researchers, patient advocates, and industry partners to share the latest advances in blood cancers, rare blood disorders, diagnostics, and therapeutic innovation.

Malaysian Society of Haematology (MSH) Scientific Conference | July 24-26 | Penang, Malaysia

Max staff will have a booth at the MSH alongside our local patient support group, Max Family Society Malaysia. The MSH Scientific Conference convenes hematologists, oncologists, researchers, and healthcare professionals across the region to exchange clinical insights, research findings, and best practices in hematology and blood cancer care, with a strong focus on regional challenges and innovations.